Delivery Order SPE2DB25D3404-SPE2DB25FUMWS

Award Date 4/9/25
Potential Completion Date 4/30/25
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 50 unit vials, with a ceiling value of $1,823.64. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 1, 2025. This contract is not set aside and was awarded on April 10, 2025. AmerisourceBergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,704.88 firm fixed-price delivery order is for the supply of 4,567,553,409 units of XEOMIN 100 unit vials. The contract has an ultimate completion date of April 1, 2025 and was awarded on March 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $23,467.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 100 unit vials, a pharmaceutical product, with an ultimate completion date of April 14, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, with a ceiling value of $1,396.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a delivery order, provides for the procurement of XEOMIN 100 UNIT VIALS. The contract has an ultimate completion date of February 6, 2025 and uses a firm-fixed-price pricing type. The award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,823.64, is for the delivery of XEOMIN 50 unit vials. It is a firm fixed-price Delivery Order contract with an ultimate completion date of April 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,174.80 firm-fixed-price contract is for the delivery of 4,567,321 units of XEOMIN 100 unit vials. The contract has a period of performance through March 12, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,118.20, is a Firm Fixed Price Delivery Order for the supply of XEOMIN 50 unit vials. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,033.28, is for the delivery of XEOMIN 200 unit vials, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of December 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 100 unit vials, a pharmaceutical product, with a ceiling value of $9,744.28 and a term through February 14, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,174.80 Firm Fixed Price contract is for the delivery of XEOMIN 200 UNIT VIALS, with a completion date of February 3, 2025. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical. This IDC serves as a primary...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUMWS
    Delivery Order

This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $8,381.10, is for the delivery of XEOMIN 100 unit vials. The contract has an ultimate completion date of April 30, 2025 and was awarded on April 9, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/9/25, 9:54 AM